Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response (Q71798796)
Jump to navigation
Jump to search
scientific article published on 01 November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response |
scientific article published on 01 November 1995 |
Statements
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response (English)
F B Ruymann
T Vietti
E Gehan
E Wiener
M Wharam
W A Newton
1 November 1995